Terminated PHASE1 INTERVENTIONAL 3-arm NCT00438321

Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome

Sponsor: American Diabetes Association

Interventions Anastrozole Pill Placebo Testosterone gel Zoladex

Updated 6 times since 2017 Last updated: Apr 14, 2017 Started: Sep 30, 2006 Primary completion: Feb 26, 2010 Completion: Feb 26, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI relocated

Other terminated trials from American Diabetes Association

See all terminations from American Diabetes Association

Other Metabolic Syndrome trials with similar outcome

Browse all Metabolic Syndrome trials

This PHASE1 trial investigates Metabolic Syndrome and is currently terminated or withdrawn. American Diabetes Association leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Jun 2017 — Jun 2018 [monthly]

Terminated PHASE1

Status: Unknown Status → Terminated · Phase: NA → PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Unknown Status NA

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Diabetes Association
Massachusetts General Hospital
National Institutes of Health (NIH)

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States